aTyr Pharma Inc.

NASDAQ: ATYR · Real-Time Price · USD
4.90
-0.09 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
4.93
0.61%
After-hours: Aug 15, 2025, 07:48 PM EDT

aTyr Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 235K 235K 588K 588K 353K 10.74M 10.39M 10.39M 10.39M n/a n/a n/a n/a 2.05M 2.2M 2.39M
Cost of Revenue
1.33M 1.33M 1.72M 1.95M 2.55M 2.76M 2.74M 3.03M 2.45M 2.15M 1.7M 1.32M 1.23M 947K 649K 329K n/a n/a
Gross Profit
-1.33M -1.33M -711K -943K -1.2M -1.4M -2.39M 7.71M 7.93M 8.23M 8.69M -1.32M -1.23M -947K -649K 1.72M 2.2M 2.39M
Operating Income
-70.05M -67.05M -67.91M -68.05M -62.52M -58.77M -54.92M -46.91M -47.79M -46.81M -46.4M -47.09M -41.33M -39.19M -34.02M -30.32M -29.1M -24.97M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-66.64M -63.42M -64.02M -63.81M -57.9M -53.93M -50.4M -43.16M -45.06M -45.14M -45.34M -46.38M -40.8M -38.78M -33.78M -30.15M -29.08M -25.14M
Net Income
-66.64M -63.41M -64.02M -63.82M -57.9M -53.93M -50.39M -43.15M -45.05M -45.14M -45.34M -46.38M -40.8M -38.77M -33.77M -30.14M -29.07M -25.13M
Selling & General & Admin
15.82M 14.23M 13.78M 12.98M 11.3M 11.09M 10.24M 10.17M 11.72M 11.76M 12.29M 11.92M 10.97M 10.6M 10.1M 10.03M 9.81M 9.17M
Research & Development
54.23M 52.82M 54.37M 54.9M 50.41M 46.28M 42.29M 44.45M 44M 43.29M 42.81M 33.85M 29.12M 27.64M 23.26M 22.01M 21.48M 18.19M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
70.05M 67.05M 68.15M 67.88M 61.71M 57.37M 52.53M 54.62M 55.72M 55.05M 55.09M 45.78M 40.1M 38.24M 33.37M 32.04M 31.3M 27.36M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a -407K -1.4M -1.99M -2.74M -3.03M -2.45M -1.87M -1.11M -414K n/a n/a n/a n/a n/a n/a
Cost & Expenses
70.05M 67.05M 68.15M 68.29M 63.11M 59.36M 55.27M 57.65M 58.17M 57.2M 56.79M 47.09M 41.33M 39.19M 34.02M 32.37M 31.3M 27.36M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2K -4K -4K -4K -2K n/a n/a
Shares Outstanding (Basic)
90.12M 86.49M 82.72M 75.8M 72.28M 66.08M 59.26M 57.89M 55.14M 41.9M 29.12M 28.66M 28.06M 27.82M 27.79M 18.16M 16.13M 14.1M
Shares Outstanding (Diluted)
90.12M 86.49M 82.72M 75.8M 72.28M 66.08M 59.26M 57.89M 55.14M 41.9M 29.12M 28.66M 28.06M 27.82M 27.79M 18.16M 16.13M 14.1M
EPS (Basic)
-0.8 -0.81 -0.87 -0.94 -0.91 -0.9 -0.96 -0.97 -1.23 -1.45 -1.6 -1.65 -1.61 -1.81 -1.88 -2.04 -2.3 -2.35
EPS (Diluted)
-0.8 -0.81 -0.87 -0.94 -0.91 -0.9 -0.96 -0.97 -1.23 -1.45 -1.6 -1.65 -1.61 -1.81 -1.88 -2.04 -2.3 -2.35
EBITDA
-69.28M -65.9M -66.37M -66.11M -59.97M -56.01M -52.18M -43.88M -45.34M -44.66M -44.71M -45.78M -40.1M -37.89M -32.71M -29.09M -27.9M -23.77M
EBIT
-69.27M -67.05M -67.91M -68.05M -62.52M -58.77M -54.92M -46.91M -47.79M -46.81M -46.4M -47.09M -41.33M -39.19M -34.02M -30.32M -29.1M -24.97M
Depreciation & Amortization
1.16M 1.15M 1.54M 1.95M 2.55M 2.76M 2.74M 3.03M 2.45M 2.15M 1.7M 1.32M 1.23M 1.3M 1.3M 1.23M 1.2M 1.21M